Literature DB >> 15997418

Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease.

G Gossrau1, B Herting, S Möckel, A Kempe, R Koch, H Reichmann, J B Lampe.   

Abstract

Idiopathic Parkinson's disease (IPD) is a neurodegenerative disorder of unknown aetiology. Histopathological similarities between IPD and Creutzfeldt-Jakob prion disease (CJD) have been suggested. Homozygosity at polymorphic prion protein gene codon 129 (PRNP129) is a risk factor for developing CJD. Therefore we investigated a putative genetic link between CJD and IPD by studying PRNP129 genotype segregation in 81 patients with IPD. We did not ascertain a different PRNP129 genotype distribution in IPD patients compared to healthy Germans. We found a significant difference in PRNP129 genotype in dependence of the clinical predominance type of IPD. Patients with tremor-dominant IPD presented less frequent a methionine homozygosis at PRNP129 than hypokinetic-rigid IPD patients (30% versus 62.5%; p<0.033). In conclusion, genotype distribution at codon 129 is obviously not essential in determining IPD. But our results may provide first evidence of an association between certain PRNP129 polymorphisms and the clinical presentation of IPD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15997418     DOI: 10.1007/s00702-005-0329-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  35 in total

1.  The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.

Authors:  Alexander Zimprich; Bertram Müller-Myhsok; Matthew Farrer; Petra Leitner; Manu Sharma; Mary Hulihan; Paul Lockhart; Audrey Strongosky; Jennifer Kachergus; Donald B Calne; Jon Stoessl; Ryan J Uitti; Ronald F Pfeiffer; Claudia Trenkwalder; Nikolaus Homann; Erwin Ott; Karoline Wenzel; Friedrich Asmus; John Hardy; Zbigniew Wszolek; Thomas Gasser
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

2.  Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection.

Authors:  Silvio M Zanata; Marilene H Lopes; Adriana F Mercadante; Glaucia N M Hajj; Luciana B Chiarini; Regina Nomizo; Adriana R O Freitas; Ana L B Cabral; Kil S Lee; Maria A Juliano; Elizabeth de Oliveira; Saul G Jachieri; Alma Burlingame; Lan Huang; Rafael Linden; Ricardo R Brentani; Vilma R Martins
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

3.  Chaperone-like activity of synucleins.

Authors:  J M Souza; B I Giasson; V M Lee; H Ischiropoulos
Journal:  FEBS Lett       Date:  2000-05-26       Impact factor: 4.124

4.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

5.  Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease.

Authors:  S T MacDonald; K Sutherland; J W Ironside
Journal:  Neuropathol Appl Neurobiol       Date:  1996-08       Impact factor: 8.090

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene.

Authors:  J J Hauw; V Sazdovitch; J L Laplanche; K Peoc'h; N Kopp; J Kemeny; N Privat; N Delasnerie-Lauprêtre; J P Brandel; J P Deslys; D Dormont; A Alpérovitch
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

9.  Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study.

Authors:  C Berr; F Richard; C Dufouil; C Amant; A Alperovitch; P Amouyel
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

10.  A common LRRK2 mutation in idiopathic Parkinson's disease.

Authors:  William P Gilks; Patrick M Abou-Sleiman; Sonia Gandhi; Shushant Jain; Andrew Singleton; Andrew J Lees; Karen Shaw; Kailash P Bhatia; Vincenzo Bonifati; Niall P Quinn; John Lynch; Daniel G Healy; Janice L Holton; Tamas Revesz; Nicholas W Wood
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

View more
  8 in total

1.  Prion protein gene M129 allele is a risk factor for Alzheimer's disease.

Authors:  M Gacia; K Safranow; M Styczyńska; K Jakubowska; B Pepłońska; M Chodakowska-Zebrowska; I Przekop; A Słowik; E Golańska; K Hułas-Bigoszewska; D Chlubek; D Religa; C Zekanowski; M Barcikowska
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

2.  The prion protein M129V polymorphism: longevity and cognitive impairment among Polish centenarians.

Authors:  Ewa Golanska; Monika Sieruta; Elizabeth Corder; Sylwia M Gresner; Anna Pfeffer; Malgorzata Chodakowska-Zebrowska; Tomasz M Sobow; Izabela Klich; Malgorzata Mossakowska; Aleksandra Szybinska; Maria Barcikowska; Pawel P Liberski
Journal:  Prion       Date:  2013-02-13       Impact factor: 3.931

3.  Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Authors:  Bronwen Martin; Wayne Chadwick; Wei-na Cong; Nick Pantaleo; Caitlin M Daimon; Erin J Golden; Kevin G Becker; William H Wood; Olga D Carlson; Josephine M Egan; Stuart Maudsley
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 4.  Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

5.  PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease.

Authors:  Cyndya Shibao; Emily M Garland; Alfredo Gamboa; Cindy L Vnencak-Jones; M Van Woeltz; Jonathan L Haines; Chang Yu; Italo Biaggioni
Journal:  Clin Auton Res       Date:  2008-01-30       Impact factor: 4.435

6.  Mutational analysis of PRNP in Alzheimer's disease and frontotemporal dementia in China.

Authors:  Weiwei Zhang; Bin Jiao; Tingting Xiao; Chuzheng Pan; Xixi Liu; Lin Zhou; Beisha Tang; Lu Shen
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

7.  Polymorphism distribution of prion protein codon 117, 129 and 171 in Taiwan.

Authors:  Kaw-Chen Wang; Vinchi Wang; Ming-Chieh Sun; Ti-I Chiueh; Bing-Wen Soong; Din-E Shan
Journal:  Eur J Epidemiol       Date:  2007-04-05       Impact factor: 12.434

8.  A Chinese patient with the clinical features of Parkinson's disease contains a single copy of octarepeat deletion in PRNP case report.

Authors:  Qi Shi; Xiao-Jing Shen; Li-Ping Gao; Kang Xiao; Wei Zhou; Yuan Wang; Cao Chen; Xiao-Ping Dong
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.